CompanyIRWDNasdaqBoston, MA

Ironwood Pharmaceuticals Inc

Ironwood Pharmaceuticals develops therapies for gastrointestinal and rare diseases.

SEC EDGAR ClinicalTrials.gov ironwoodpharma.com

424B3Sep 25Latest SEC filing

Aug 6Latest story

August 2026

Ironwood raises 2026 guidance again as apraglutide trial recruits and debt is repaid

Aug 6Quarterly updateAbbVie Ironwood Pharmaceuticals Inc